The global bone cement and glue market is characterized by steady expansion, with its valuation rising from US$1,549 million in 2022 to US$1,644 million in 2023. This market is projected to reach US$2,248 million by 2028, progressing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. This growth is primarily fueled by a rising volume of surgical procedures and a significant increase in road traffic accidents requiring orthopedic intervention.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131540876

\<h3>What are the key drivers influencing the growth of the Market?\</h3>\<p>The primary driver for market expansion is the increasing incidence of sports-related injuries globally. Factors such as growing participation in fitness activities, competitive intensity, and insufficient recovery times have led to millions of injuries annually, particularly affecting children and adolescents in the United States. Many of these injuries, specifically those involving the hip, knee, and shoulder, necessitate arthroplasty procedures where bone cement is essential for anchoring prosthetic implants.\</p>\<p>Additionally, the market is bolstered by the rising number of surgical procedures and road traffic accidents. The necessity for effective bone stabilization in trauma cases and joint replacements remains a constant requirement, ensuring a consistent demand for high-quality synthetic polymer-based materials and biological adhesives.\</p>\<h3>What are the major restraints limiting the growth of the Market?\</h3>\<p>High research and development costs represent a significant barrier to market growth. Developing innovative bone cement products requires substantial financial investment, which often limits the participation of smaller firms and startups. Furthermore, stringent regulatory environments, particularly the FDA approval process, demand extensive clinical data regarding safety and efficacy, leading to prolonged timelines and additional financial burdens for manufacturers.\</p>\<p>The availability of alternative fixation methods also restrains market uptake. Orthopedic pins and bone staples serve as viable substitutes in certain clinical scenarios, diverting potential demand away from advanced bone cement and glue products. These factors collectively pressure companies to reevaluate their product development budgets and market entry strategies.\</p>\<h3>What emerging opportunities are expected to shape the future of the Market?\</h3>\<p>The increasing preference for minimally invasive surgeries (MIS) presents a significant growth opportunity. These procedures offer patients benefits such as smaller incisions, reduced post-operative pain, and faster recovery times. As the adoption of surgical robotics and specialized MIS techniques grows, there is a corresponding demand for specialized bone cement and glue products tailored specifically for these less invasive approaches.\</p>\<p>From a healthcare economics perspective, minimally invasive procedures are increasingly viewed as cost-effective solutions. Research indicates that reducing hospital stays through MIS can result in direct savings of approximately USD 1,500 per day. Consequently, bone cement products that support these efficient surgical models align with the cost-reduction goals of modern healthcare systems.\</p>\<h3>What are the critical challenges faced by stakeholders in the Market?\</h3>\<p>Stakeholders must navigate various product-related complications that can impact patient outcomes and clinical success. Common issues include post-operative infections, allergic reactions to methacrylate monomers, and cement leakage into surrounding tissues or blood vessels. These complications can lead to implant loosening, nerve impingement, or the need for complex revision surgeries.\</p>\<p>Technical challenges during the application process, such as thermal necrosis caused by the heat generated during polymerization, also remain a concern. Furthermore, while antibiotic-loaded bone cements are used to prevent infection, they introduce risks such as antibiotic resistance, systemic toxicity, and potential alterations to the mechanical properties of the cement itself.\</p>\<h3>Who are the leading players operating in the Market?\</h3>\<p>The competitive landscape is dominated by several key medical technology companies, including Stryker, Zimmer Biomet, Smith+Nephew, and DePuy Synthes, a subsidiary of Johnson & Johnson. Other significant participants include Enovis, Artivion, Inc., Cardinal Health, Medtronic, Globus Medical, and Heraeus Holding.\</p>\<p>These market leaders frequently engage in strategic acquisitions and internal reorganizations to enhance their product portfolios. For instance, recent industry activity includes Smith & Nephew’s acquisition of extremity orthopedics assets and Zimmer Biomet’s spinoff of its spine and dental businesses into ZimVie Inc. to focus on core orthopedic segments.\</p>\<h3>What are the key segments of the Market based on type, application, and end user?\</h3>\<p>The market is segmented by type into bone cement (including PMMA, CPC, and GPC) and bone glue (natural and synthetic). The PMMA segment is expected to grow at the highest CAGR due to its widespread use in arthroplasty and vertebral procedures. Loading types include antibiotic-loaded and non-antibiotic-loaded cements, with the former gaining traction for its role in localized infection prevention.\</p>\<p>By application, the market is categorized into arthroplasty (knee, hip, and shoulder), kyphoplasty, and vertebroplasty, with arthroplasty currently dominating due to the prevalence of osteoarthritis and the aging population. End users primarily consist of hospitals and ambulatory surgical centers (ASCs), where specialized orthopedic care and cost-effective treatments are delivered.\</p>\<h3>Which regions are dominating and emerging in the Market?\</h3>\<p>North America currently holds the largest share of the market, driven by a well-established healthcare system, high prevalence of target diseases, and a strong presence of major market players. The region’s growth is further supported by an aging geriatric population and ongoing investments in hospital infrastructure and surgical capabilities.\</p>\<p>In contrast, the Asia Pacific region, particularly India, is emerging as a high-growth market. This is attributed to the rise of medical tourism in the orthopedic sector and an increasing elderly population susceptible to degenerative joint diseases. In Europe, Germany is identified as a leading market due to its high volume of orthopedic cases and intensive research and development activities.\</p>

Inquire Before Buying-https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=131540876